These data highlight PPIA, MMP-9, and GFAP as key disease biomarkers, so their measurement in association with NFL, an established marker of brain injury, may help identify a blood signature for disease severity and neurological complications in COVID-19 patients (NeuroCovid). The gene discussed is GFAP; the disease is COVID-19.